Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.


Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 06 04 2020
revised: 09 04 2020
accepted: 09 04 2020
pubmed: 26 4 2020
medline: 27 6 2020
entrez: 26 4 2020
Statut: ppublish

Résumé

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments.

Identifiants

pubmed: 32334323
pii: S0960-9776(20)30093-X
doi: 10.1016/j.breast.2020.04.006
pmc: PMC7162626
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-16

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
CNS Spectr. 2020 Feb;25(1):79-100
pubmed: 31010446
Lancet Oncol. 2015 Mar;16(3):266-73
pubmed: 25637340
Lancet. 2019 Jun 29;393(10191):2599-2612
pubmed: 31178152
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Breast. 2020 Jun;51:65-84
pubmed: 32217457
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281
pubmed: 32241520
Ann Oncol. 2019 Oct 1;30(10):1674
pubmed: 31236598
Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1166-1172
pubmed: 29165285
N Engl J Med. 2010 Feb 11;362(6):513-20
pubmed: 20147717
BMJ. 2020 Mar 25;368:m1174
pubmed: 32213482
Cancer Treat Rev. 2017 Jan;52:58-70
pubmed: 27894012
Breast Cancer Res Treat. 2020 Jul;182(2):511-512
pubmed: 32451680
Eur J Cancer. 2015 Mar;51(4):451-63
pubmed: 25605582
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Lancet Oncol. 2013 Dec;14(13):1269-77
pubmed: 24225155
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Br J Cancer. 2017 Jul 11;117(2):179-188
pubmed: 28588320
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Radiother Oncol. 2016 Jul;120(1):114-8
pubmed: 27046390
Support Care Cancer. 2020 Aug;28(8):3921-3926
pubmed: 31858249
Psychooncology. 2019 Mar;28(3):553-560
pubmed: 30614141
Lancet Oncol. 2015 Jan;16(1):47-56
pubmed: 25500422

Auteurs

Giuseppe Curigliano (G)

Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.

Maria Joao Cardoso (MJ)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal; Nova Medical School, Lisbon, Portugal.

Philip Poortmans (P)

Iridium Kankernetwerk, Department of Radiation Oncology, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium.

Oreste Gentilini (O)

Breast Surgery, San Raffaele University and Research Hospital, Milano, Italy.

Gabriella Pravettoni (G)

Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.

Ketti Mazzocco (K)

Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.

Nehmat Houssami (N)

Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.

Olivia Pagani (O)

Service Interdisciplinaire de Cancérologie, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Switzerland.

Elzbieta Senkus (E)

Medical University of Gdansk, Gdansk, Poland.

Fatima Cardoso (F)

Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH